Published in
Elsevier, Gynecologic Oncology, 2(136), p. 212-217
DOI: 10.1016/j.ygyno.2014.11.017
Links
Tools
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
Journal article published in 2015 by
Sook Hee Hong,
Soohyeon Lee,
Hoon-Gu Kim,
Hyo Jin Lee,
Kyung Hae Jung,
Sang-Cheol Lee,
Na-Ri Lee,
Jina Yun,
In Sook Woo,
Kyong Hwa Park,
Kyoung-Ha Kim,
Ho Young Kim,
Sun Young Rha 
,
Jae Ho Byun
,
Jae Ho Byun
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 